DUSA Pharmaceuticals, Inc.赞助的临床试验
总计5582个结果
-
DUSA Pharmaceuticals, Inc.终止
-
DUSA Pharmaceuticals, Inc.撤销
-
Southern Illinois UniversityDUSA Pharmaceuticals, Inc.完全的
-
Tufts Medical CenterDUSA Pharmaceuticals, Inc.完全的
-
Medical Dermatology SpecialistsDUSA Pharmaceuticals, Inc.完全的
-
Hinova Pharmaceuticals USA, Inc.主动,不招人去势抵抗性前列腺癌 | 前列腺癌转移德国, 西班牙, 丹麦, 法国, 英国, 俄罗斯联邦, 波兰, 澳大利亚, 意大利, 荷兰, 美国, 芬兰, 加拿大, 奥地利
-
Mimetogen Pharmaceuticals USA, Inc.完全的
-
Dartmouth-Hitchcock Medical CenterDUSA Pharmaceuticals, Inc.完全的
-
Teva Pharmaceuticals USATeva Pharmaceuticals, Inc.完全的
-
Actavis Inc.Teva Pharmaceuticals USA完全的
-
Teva Pharmaceuticals USATeva Pharmaceuticals Development, Inc.完全的
-
University of Alabama at BirminghamDUSA Pharmaceuticals, Inc.完全的
-
Goldman, Butterwick, Fitzpatrick and GroffDUSA Pharmaceuticals, Inc.完全的
-
Teva Pharmaceuticals USATeva Branded Pharmaceutical Products R&D, Inc.完全的
-
Massachusetts General HospitalAlkermes, Inc.; Otsuka America Pharmaceutical; Eisai Inc.; Janssen Pharmaceuticals; Sage Therapeutics 和其他合作者招聘中
-
Yuejia Pharmaceuticals (USA), Inc.Zhejiang Yuejia Pharmaceuticals Co., Ltd.完全的
-
Edward Maytin, MD, PhDDUSA Pharmaceuticals, Inc.完全的
-
Genzada Pharmaceuticals USA, Inc.Translational Drug Development主动,不招人肉瘤 | 淋巴瘤 | 乳腺癌 | 胃癌 | 胰腺癌 | 实体瘤 | 皮肤T细胞淋巴瘤 | 晚期癌症 | 头颈部鳞状细胞癌 | 结直肠癌 | 皮肤T细胞淋巴瘤 | 前列腺癌转移 | 基底细胞癌 | 实体癌 | 胃实体癌 | 胃癌 | 皮肤鳞状细胞癌美国